Clinical Quiz: Risk Assessment from 2019 ESC/EAS Guidelines on Dyslipidemia

The management of dyslipidemia has experienced significant changes in recent decades driven by advances in understanding pathophysiology as well as developments in pharmacological therapies.

For decades, statins were not only the centerpiece, but often the only option for many patients who struggled with lipid disorders. While their role as a mainstay in therapy has persisted through time as a result of their affordability, efficacy, and established safety profile, the advent of new therapies has redefined what is considerable an optimal approach to management of dyslipidemia for many. With such a rapid rate of advancements, the release of updated guidance has become paramount.

In this clinical quiz, we test your knowledge of risk assessment and stratification from the 2019 European Society of Cardiology/European Atherosclerosis Society Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk.

Of note, this is the first in a series of 4 quizzes based on these guidelines. Check back for more quizzes on risk assessment, pharmacotherapy, and nonpharmacologic interventions in the coming weeks!

Please click here after selecting answer

Quiz 1: Lipid Management Principles from 2019 ESC/EAS Guidelines on Dyslipidemia

Quiz 2: Risk Assessment and Stratification from 2019 ESC/EAS Guidelines on Dyslipidemia

Reference:

1. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk [published correction appears in Eur Heart J. 2020 Nov 21;41(44):4255. doi: 10.1093/eurheartj/ehz826]. Eur Heart J. 2020;41(1):111-188. doi:10.1093/eurheartj/ehz455

Editor’s note: this quiz was composed with the assistance of artificial intelligence tools.